Brief: RhoVac reports a positive meeting with EMA
Oct 26 (Reuters) - Rhovac Ab RHOVAC.ST :
* RHOVAC REPORTS A POSITIVE MEETING WITH THE EUROPEAN
MEDICINES AGENCY (EMA)
Source text for Eikon: ID:nWkr2dm3pl
Further company coverage: RHOVAC.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 587720920;))
Recent news on Chosa Oncology AB
See all newsBrief: Chosa Oncology Appoints Gerton Jönsson As New Chief Financial Officer
Brief: CHOSA Oncology AB Says Postpones Publication Of Interim Report Q4 2024
Brief: Chosa Oncology Carried Out Directed Issue Of Sek 1,55 Mln To Further Increase Business Development Activities
Brief: Chosa Oncology Announces Decision To Postpone Release Of Interim Report For Q2 2023
Brief: Chosa Oncology AB Publishes Results From Clinical Phase 2 Trial Of Liposomal Formulation In Breast Cancer, Using Predictive Marker For Cisplatin